Renaissance Technologies’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-25,247
| Closed | -$100K | – | 3296 |
|
|
2025
Q3 | $100K | Sell |
25,247
-7,859
| -24% | -$53.5K | ﹤0.01% | 3248 |
|
|
2025
Q2 | $397K | Sell |
33,106
-3,861
| -10% | -$47.9K | ﹤0.01% | 2949 |
|
|
2025
Q1 | $509K | Sell |
36,967
-11,152
| -23% | -$160K | ﹤0.01% | 2738 |
|
|
2024
Q4 | $686K | Sell |
48,119
-1,540
| -3% | -$25.3K | ﹤0.01% | 2692 |
|
|
2024
Q3 | $946K | Buy |
49,659
+10,813
| +28% | +$185K | ﹤0.01% | 2479 |
|
|
2024
Q2 | $757K | Buy |
38,846
+2,393
| +7% | +$46.2K | ﹤0.01% | 2480 |
|
|
2024
Q1 | $837K | Buy |
36,453
+10,807
| +42% | +$233K | ﹤0.01% | 2587 |
|
|
2023
Q4 | $450K | Buy |
25,646
+7,427
| +41% | +$106K | ﹤0.01% | 2829 |
|
|
2023
Q3 | $238K | Sell |
18,219
-4,227
| -19% | -$64K | ﹤0.01% | 3029 |
|
|
2023
Q2 | $377K | Sell |
22,446
-8,180
| -27% | -$141K | ﹤0.01% | 3020 |
|
|
2023
Q1 | $478K | Sell |
30,626
-8,533
| -22% | -$166K | ﹤0.01% | 2913 |
|
|
2022
Q4 | $658K | Sell |
39,159
-4,740
| -11% | -$85.4K | ﹤0.01% | 2778 |
|
|
2022
Q3 | $744K | Sell |
43,899
-9,954
| -18% | -$218K | ﹤0.01% | 2676 |
|
|
2022
Q2 | $1.19M | Sell |
53,853
-3,810
| -7% | -$92.5K | ﹤0.01% | 2595 |
|
|
2022
Q1 | $1.98M | Buy |
57,663
+29,049
| +102% | +$869K | ﹤0.01% | 2240 |
|
|
2021
Q4 | $1.18M | Buy |
28,614
+21,848
| +323% | +$1.42M | ﹤0.01% | 2524 |
|
|
2021
Q3 | $609K | Buy |
6,766
+2,060
| +44% | +$182K | ﹤0.01% | 2799 |
|
|
2021
Q2 | $344K | Sell |
4,706
-32,927
| -87% | -$1.53M | ﹤0.01% | 3099 |
|
|
2021
Q1 | $1.39M | Buy |
37,633
+7,007
| +23% | +$352K | ﹤0.01% | 2440 |
|
|
2020
Q4 | $1.26M | Sell |
30,626
-4,640
| -13% | -$120K | ﹤0.01% | 2386 |
|
|
2020
Q3 | $815K | Sell |
35,266
-18,830
| -35% | -$487K | ﹤0.01% | 2613 |
|
|
2020
Q2 | $1.53M | Buy |
54,096
+27,903
| +107% | +$822K | ﹤0.01% | 2328 |
|
|
2020
Q1 | $668K | Buy |
26,193
+20,280
| +343% | +$750K | ﹤0.01% | 2619 |
|
|
2019
Q4 | $257K | Buy |
+5,913
| New | +$124K | ﹤0.01% | 3106 |
|
|
2019
Q2 | – | Sell |
-1,781
| Closed | -$37K | – | 3563 |
|
|
2019
Q1 | $37K | Sell |
1,781
-31,981
| -95% | -$635K | ﹤0.01% | 3372 |
|
|
2018
Q4 | $542K | Buy |
33,762
+31,422
| +1,343% | +$1.47M | ﹤0.01% | 2835 |
|
|
2018
Q3 | $216K | Buy |
+2,340
| New | +$278K | ﹤0.01% | 3128 |
|
|
2017
Q3 | – | Sell |
-5,347
| Closed | -$731K | – | 3216 |
|
|
2017
Q2 | $731K | Buy |
5,347
+274
| +5% | +$32.9K | ﹤0.01% | 2664 |
|
|
2017
Q1 | $604K | Buy |
+5,073
| New | +$599K | ﹤0.01% | 2716 |
|
Other funds holding CLSD
Renaissance Technologies's CLSD Position: Q4 2025 in Review
Renaissance Technologies sold out of Clearside Biomedical (CLSD) in Q4 2025, closing a stake of 25,247 shares — an estimated $100K sold.
Renaissance Technologies first reported a position in CLSD in Q1 2017 and held it in 29 quarters. The position peaked at $1.98M in Q1 2022. 1 fund tracked by Wall St. Rank holds CLSD as of Q4 2025.
- Renaissance Technologies reported no remaining Clearside Biomedical position as of Q4 2025 after selling out during the quarter.
- Renaissance Technologies sold 25,247 Clearside Biomedical shares in Q4 2025, an estimated $100K.
- Renaissance Technologies first reported a position in Clearside Biomedical in Q1 2017 and held it in 29 quarters.
- Renaissance Technologies's Clearside Biomedical position peaked at $1.98M in Q1 2022.
- 1 fund tracked by Wall St. Rank held Clearside Biomedical as of Q4 2025.
Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.